Analysis of the efficacy and safety of bortezomib for treating newly diagnosed multiple myeloma through different administration methods

BACKGROUND: This study aims to compare the efficacy and adverse reactions of bortezomib for treating newly diagnosed multiple myeloma (MM) through two different administration methods: intravenous (IV) injection and subcutaneous (SC) injection. METHODS: A retrospective analysis was performed in 205...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Manag Res
Autori principali: Zhang, Hong-Mei, Liu, Xi-Yang, Liu, Yu-Zhang, Liu, Li-Na, Lin, Quan-De, Song, Yong-Ping, Fang, Bai-Jun
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove 2019
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6749981/
https://ncbi.nlm.nih.gov/pubmed/31571987
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S218979
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi